baber/WOPTO huggingface dataset:
Patent TW-I788162-B (TW)
Inventor: LIN FENG-SHENG
IPC: G09G3/34
Filed: 2021-12-27
Granted: 2022-12-21
Abstract: 本揭示文件提供一種顯示驅動電路以及顯示驅動方法，顯示驅動電路包含第一記憶體、選取控制單元以及輸出緩衝。顯示驅動電路用以藉由旋轉或鏡像的方式來處理顯示圖幀。在顯示驅動方法中，將欲處理的顯示圖幀傳送至第一記憶體。利用選取控制單元將顯示圖幀進行旋轉或鏡像，並傳送至輸出緩衝。輸出緩衝將經過旋轉或鏡像的顯示圖幀傳送至顯示面板進行顯示。
Patent TW-I814475-B (TW)
Title: 安全自動鎖具
Inventor: Xu cheng-hao
IPC: E05B17/22
Filed: 2022-07-08
Granted: 2023-09-01
Abstract: 本創作安全自動鎖具包含一殼座及裝設於殼座中的一觸發推桿、一鎖扣組件及一鎖定塊，殼座的前後兩側分別具有一旋鈕及一鎖孔，旋鈕及鎖孔分別連接鎖定塊，觸發推桿連接鎖扣組件，並自殼座的一側突出，所述安全自動鎖具能裝設一門板上，當門板被朝門框移動，使觸發推桿接觸門框時，觸發推桿會帶動鎖扣組件作動，使鎖扣組件自動呈一勾鎖狀態，透過操作旋鈕以轉動該鎖定塊，使鎖定塊抵靠鎖扣組件而維持勾鎖狀態，即能將安全自動鎖具上鎖，而若要自房間的外側將安全自動鎖具解鎖，則須以該鎖孔配合之鑰匙才能轉動該鎖定塊，藉此提升安全性。
Patent TW-I816536-B (TW)
Title: 有機發光顯示設備及其製造方法
Inventor: KIM JAESIK
IPC: H01L51/56
Filed: 2018-03-12
Granted: 2023-09-21
Abstract: 本發明係提供一種有機發光顯示設備，其包含：基板，在該基板上的第一第一電極；在第一第一電極上的第一有機功能層，第一有機功能層包含第一發光層；在第一有機功能層上的第一第二電極；在基板上的第二第一電極，第二第一電極與第一第一電極分開；在第二第一電極上的第二有機功能層，第二有機功能層包含第二發光層；在第二有機功能層上的第二第二電極；以及在第一有機功能層與第二有機功能層之間的自組裝層，自組裝層含有氟。
Patent ZA-200202018-B (ZA)
Title: Cold storage applicance.
Inventor: WOOD IAN DAVID
IPC: F25D23/02
Filed: 2002-03-12
Abstract: A cold-storage appliance comprises an open-topped insulating container defining an external surface, an insulating lid adapted to close the open top of the container, a cooling means adapted to cool the interior but not the exterior of the container, and a structure supporting the container, the lid and the cooling means. In accordance with the invention, the container is mounted to the structure for movement relative to the structure and the lid to open the container and afford access to its interior or to close the container, and at least a majority of the external surface of the container is exposed to ambient air when the container is closed by the lid.
Patent ZA-200207930-B (ZA)
Title: Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof.
Inventor: SPIEGEL SARAH
IPC: C12Q1/68
Filed: 2002-10-02
Abstract: A peptide for use in the treatment or amelioration of a disease. The peptide is a mammalian sphingosine kinase type 2 isoform and is present in a pharmaceutically acceptable amount. The disease results from increased cell death. Alternatively, the disease results from decreased cell proliferation. Alternatively, the disease results from decreased cell death. Alternatively, the disease results from increased cell proliferation. Alternatively, the disease results from abnormal migration or motility of cells.
Patent ZA-200401996-B (ZA)
Title: 1-Glyoxylamide indolizines for treating cancer.
Inventor: KOYA KEIZO
IPC: A61K31/496
Filed: 2004-03-11
Abstract: Disclosed is a compound represented by Structural Formula (I):Ring A is substituted or unsubstituted and optionally fused to an aryl group.Z1 and Z2 are independently =O, =S, =N-OR12 or =NR12R1 and R2 are independently -H, an aliphatic group, a substituted aliphatic group, an unsubstituted non-aromatic heterocylic group, a substituted non-aromatic heterocylic group, an aryl group or a substituted aryl group, provided that R1 and R2 are not both -H. Alternatively, -NR1R2, taken together, is a substituted or unsubstituted non-aromatic nitrogen-containing heterocyclic group or a substituted or unsubstituted nitrogen-containing heteroaryl group.R3 is a substituted or unsubstituted aryl group or a substituted or unsubstituted aliphatic group.X is a covalent bond, -C(R4R5)-, -N(R4)-, -O-, -S-, -S(O)-, -S(O)2-, -C(=O)-, -C(=O)-N(R4)-, or -N(R4)-C(=O)-.R4 and R5 are independently -H or a substituted or unsubstituted aliphatic group.R12 is -H or a substituted or unsubstituted alkyl group.
Patent ZA-200409430-B (ZA)
Title: Process for the manufacture of quinoline derivatives.
Inventor: JANSSON KARL
IPC: A61K31/4706
Filed: 2004-11-23
Abstract: A process for the preparation of the compounds of general formula (I); by reacting a quinoline-3-carboxylic acid ester derivative of formula A with an aniline derivative of formula B in a solvent selected from straight- or branch-chaineded alkanes and cycloalkanes or mixtures thereof with a boiling point between 80 and 200 C.
Patent ZA-200600559-B (ZA)
Title: Administration of medicinal dry powders
Inventor: THOMAS NILSSON
IPC: A61M15/00
Filed: 2004-06-15
Abstract: A method of administering a metered dry powder combined dose of finely divided dry medication powders is disclosed, wherein said method comprises providing a relative motion between a nozzle of a dry powder inhaler and a dose bed carrying said combined dose of finely divided dry medication powder intended for delivery by the dry powder inhaler, the combined dose comprises metered quantities of at least two medicaments separately deposited on the dose bed, the relative motion causing the nozzle to pass over the combined dose for a simultaneous or sequential delivery of the medicaments during the course of a single suction of air.
Patent ZA-200609719-B (ZA)
Title: Polish composition for leather or synthetic leather
Inventor: JASON RADLEY
IPC: C14C11/00
Filed: 2006-11-22
Abstract: A polish composition for treating a leather and/or synthetic leather article, said composition comprising water, at least one way, at least one film-forming polymer, and a layered silicate incorporating an inorganic peptiser.
Patent MX-291624-B (MX)
Title: Immunogens from uropathogenic escherichia coli.
Inventor: MASIGNANI VEGA
Filed: 2006-02-17
Abstract: Disclosed herein is a gene that can be included in immunogenic compositions specific for pathogenic  E. coli  strains. The gene is from uropathogenic strains but is absent from non-pathogenic strains, and its encoded protein has cellular locations which render it accessible to the immune system.
Patent MX-338486-B (MX)
Title: METHOD FOR THE EARLY DIAGNOSIS OF OSTEOARTHRITIS BY THE DETECTION OF INTERLEUKIN IL-1ß.
Inventor: FLORES JUAN BAUTISTA KOURI
IPC: G01N33/00
Filed: 2010-08-26
Abstract: The present invention refers to a method of detection of interleukin IL-1ß for the diagnosis of osteoarthritis at early stages. The method also refers to the relationship of the pro-inflammatory and anti-inflammatory cytokines expression in a healthy cartilage and an ostearthritic cartilage. The detection method consists in inducing the OA by means of a partial menisectomy and a workout of high impact, and removing samples of cartilage under aseptic conditions. The present invention also refers to the determination of the expression changes in proteins in the cartilage during the osteoarthritis progression.
Patent MX-354904-B (MX)
Title: COMBINED USE OF CRY1Ca AND CRY1Fa PROTEINS FOR INSECT RESISTANCE MANAGEMENT.
Inventor: MEADE THOMAS
IPC: C12N15/82
Filed: 2010-12-16
Abstract: The subject invention includes methods and plants for controlling lepidopteran insects, said plants comprising a CrylFa insecticidal protein and a Cry1Ca insecticidal protein, in combination, to delay or prevent development of resistance by the insect(s).
Patent MX-347588-B (MX)
Title: Chipboard including paper, aluminum and polyethylene.
Inventor: SANDRA JARA CASTRO
IPC: B32B23/06
Filed: 2012-07-19
Abstract: The present invention consists in a chipboard including aluminum, paper and polyethylene, where said compounds may result from waste materials such as juice, milk and beverage packs as well as plastic bags. The composition of the invention comprises the following ranges: 15%-75% of low-density polyethylene, 10%-70% of high-density polyethylene, 14%-56% of paper and 1%-4% of aluminum. The chipboard components provide the required properties for the respective application thereof, presenting improved characteristics of flexibility, impact and waterproof resistance compared to other type of chipboards such as plywood. The present invention may replace the use of wood or the like, in the construction or furniture area.
Patent MX-370090-B (MX)
Title: Method and system for the integral treatment of wastewater from the maize industry.
Inventor: ALI ASAFF TORRES
IPC: C02F1/44
Filed: 2013-02-01
Abstract: The invention relates to a novel integral process for the treatment of wastewater, commonly known as nejayote, from the nixtamal, masa and tortilla industry, comprising an improved method for removing the insoluble fraction and a filtration system for separating and concentrating the fractions forming the nejayote. The method comprises the steps of: (a) neutralising the nejayote; (b) enzymatically hydrolysing the starch granules; (c) flocculating and separating the insoluble fraction. The system comprises the steps of (a) microfiltration; (b) ultrafiltration for concentrating long-chain carbohydrates; (c) ultra/nano filtration for concentrating medium-size compounds; (d) nanofiltration/reverse osmosis for concentrating small molecules and obtaining water of sufficient quality that it can be re-used or safely discharged into the environment. In one embodiment of the invention, in order to remove unwanted phenolic compounds, the process includes a method comprising the steps of: (a) aci difying the effluents at pH <4; (b) flocculating and separating the unwanted insoluble fraction.
Patent MX-347934-B (MX)
Title: Device and method for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus.
Inventor: GIOVANNI CAVALLO
IPC: A61N1/30
Filed: 2011-01-12
Abstract: An ocular iontophoresis device for delivering any ionized drug solution, such as riboflavin solution, to the cornea comprises, in combination: a reservoir (8) containing a riboflavin solution which is suitable to be merely positioned on the eye; an active electrode (2) disposed in or on the reservoir (8); and a passive electrode suitable to be placed on the skin of the subject, elsewhere on the body, preferably in close vicinity of the eye, such as forehead, cheeks or neck; means (10) for irradiating the cornea surface with suitable light, such as UV light, for obtaining corneal' cross- linking after the delivering of drug or of Riboflavin; wherein said reservoir (8) and said active electrode (2) are transparent to UV light and/or visible light and/or IR light. Method for delivering any ionized drug solution, such as riboflavin solution, to the cornea for treatment of keratoconus or any other ectasic corneal disease, or for reinforcing corneal stromal structure by means of an ocular iontophoresis device according to preceding claims, providing the following steps : - positioning said iontophoretic device on the eye to be treated, the device comprising a reservoir containing the riboflavin solution; - driving the solution movement by a cathodic current applied for 0,5 to 5 min, at an intensity not higher than 2 mA; - irradiation, immediately after the end of the current application, of the cornea surface with an UV light for 5 to 30 min at a power of 3 to 30 mW/cm2; thereby obtaining the corneal cross-linking of the riboflavin.
Patent MX-338349-B (MX)
Title: A centrifugal separator, wear resistance member and set of wear resistance members for a centrifugal separator.
Inventor: LENDZIAN WILLI B
IPC: B04B7/12
Filed: 2011-11-10
Abstract: A centrifugal separator comprises a bowl with a conical part (17) with a narrow discharge end (15) comprising a radial surface (19); an end member (21) opposite the radial surface; a number of distance members extending between the radial surface (19) and the end member (21) and providing outlet openings (10) between adjacent distance members (27); and wear resistance members covering surfaces at the outlet openings, wherein the wear resistance members comprise bushing members (29) with mantle portions (31) surrounding respective distance members (27).
Patent MX-365647-B (MX)
Title: Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf).
Inventor: DEAN NICHOLAS M
IPC: C12N15/113
Filed: 2012-02-02
Abstract: This invention provides methods of preventing formation of, or treating, fibrotic lesions, including skin scars such as keloids and hypertrophic scars which comprise administering to the subject by one or more injection a compound which comprises a modified oligonucleotide, such as a modified antisense oligonucleotide, siRNA, or oligodeoxyribonucleotide, which inhibits expression of protein involved in fibrosis. Dosing of the antisense using an intradermal threading technique is also described.
Patent MX-361979-B (MX)
Title: Magnesium chloride in alcoholic solvent for sorel cement.
Inventor: B RAGHAVA REDDY
IPC: C04B9/02
Filed: 2013-09-18
Abstract: A non-hydraulic cement composition including: (i) a non-aqueous liquid phase comprising one or more organic compounds characterized by: (a) having at least one hydroxyl group on a carbon atom, (b) being a liquid when pure under Standard Laboratory Conditions, and (c) being at least soluble in water; (ii) one or more magnesium chloride compounds selected from the group consisting of: magnesium chloride, a magnesium chloride hydrate, and any combination thereof; and (iii) magnesium oxide; wherein the one or more organic compounds comprise at least 40% by weight of the non-aqueous liquid phase excluding the weight of any dissolved solids. A method of treating a well including the steps of: (A) forming the non-hydraulic cement composition; and (B) introducing the non-hydraulic cement composition into the well.
Patent MX-367013-B (MX)
Title: Cd40l-specific tn3-derived scaffolds and methods of use thereof.
Inventor: ANTHONY COYLE
IPC: G16B45/00
Filed: 2012-10-10
Abstract: The present invention provides Tenascin-3 Fnlll domain-based scaffolds that specifically bind to CD40L. The invention further provides engineered variants with increased affinity for the target. The present invention is also related to engineered scaffolds as prophylactic, diagnostic, or therapeutic agents, in particular for therapeutic uses against SLE and other autoimmune diseases and conditions.
Patent MX-340531-B (MX)
Title: (meth)acrylate compound, and photochromic curable composition containing said (meth)acrylate compound.
Inventor: JUNJI MOMODA
IPC: C08L33/14
Filed: 2012-10-15
Abstract: A photochromic curable composition according to the present invention is characterized by comprising: a (meth)acrylate compound represented by formula (1-X1) (wherein Y represents an oxygen atom or a bivalent group represented by -NH-; R1 and R2 independently represent a hydrogen atom or a methyl group; R3 represents an alkylene group having 1-6 carbon atoms; R4 represents an alkylene group having 1-6 carbon atoms, a cycloalkylene group having 3-8 carbon atoms which may contain a double bond, or an arylene group having 6-10 carbon atoms; and a represents a positive integer of 1-20); another radically polymerizable monomer; and a photochromic compound. According to the present invention, it becomes possible to produce a lens which does not undergo the surface hazing caused by bleed out or the delamination during the process of the production thereof, has excellent durability, and can exhibit high photochromic performance.
Patent MX-357147-B (MX)
Title: Heat sealable coated nylon.
Inventor: YUAN-PING R TING
IPC: C08J5/18
Filed: 2013-02-27
Abstract: A heat sealable coated nylon film comprising a layer having a first and a second surface, the layer consisting essentially of nylon, and a coating on the first surface of said layer, wherein the coating is water-based and adapted for making the coated nylon film heat sealable and wherein the coating comprises a polyurethane and a polymer selected from the group consisting of polyolefin, EVA, EAA, ethylene methacrylic copolymer, and a combination thereof. A processes of forming said coated nylon film, a packaged product comprising a product and said heat sealable coated nylon film in which the product is wrapped, and a process of packaging said product.
Patent MX-369114-B (MX)
Title: Process for the preparation of polysaccharide nanoparticles.
Inventor: WASIAK IGA
IPC: C08B37/02
Filed: 2013-03-12
Abstract: The process for the preparation of nanoparticles from polysaccharides and derivatives thereof, by their specific partial oxidation to produce aldehyde groups and attach compounds with amino or other group with the R-NH2 bond which react with aldehyde groups, comprising oxidizing the polysaccharide or derivative thereof by a known method to obtain aldehyde groups until the oxidation degree of 0,1% to 80% of the sugar rings is obtained, then adding at least one nanoparticle-forming agent which after attachment of the aldehyde group exhibits hydrophobic properties, selected from the group comprising: aliphatic or aromatic organic amines containing from 4 to 20 carbon atoms, amides and hydrazides of aliphatic and aromatic organic acids containing from 4 to 20 carbon atoms, hydrophobic amino acids, phosphatidylethanolamine, and at least one active substance containing at least one amino, amido or hydrazide group, to the solution of the oxidized polysaccharide in water or a mixture of water and an organic solvent, carrying the reaction out at pH of the solution from 1 to 9, at the temperature of from 10 to 100°C, wherein the total molar ratio of amino groups to aldehyde groups is from 20 to 0,5.
Patent MX-354728-B (MX)
Title: Plastic packages for dispensing aerosol products having improved crazing resistance and sustainability.
Inventor: DIMITRIS IOANNIS COLLIAS
IPC: B65D83/14
Filed: 2013-04-16
Abstract: A plastic package for dispensing a product in aerosol form having improved crazing resistance and sustainability is disclosed. The plastic package comprises a bottle having a delivery device, a valve to control flow, and a stable plastic package that holds the product when sealed using the valve. In one embodiment, at least a portion of the plastic package comprises PEF.
Patent MX-360123-B (MX)
Title: METHOD and STRUCTURE FOR CHEMICAL ANALYSIS.
Inventor: ANTTALAINEN OSMO
IPC: G01N27/624
Filed: 2013-04-19
Abstract: The invention relates to a method for chemical analysis, in which a gas flow is ionized, the ionized gas flow (24) is led to a filtering area (28) fitted to the flow channel (18), the ionized gas flow is filtered using the DMS/FAIMS method, in order to remove at least some of the ions (25, 105) from the gas flow. A parallel mainly non-ionized gas flow (13), which is on at least one side of the ionized gas flow, is led to the filtering area together with the ionized gas flow. The invention also relates to a. corresponding structure.
Patent MX-363448-B (MX)
Title: Hydrogen peroxide vaporizer.
Inventor: AARÓN L HILL
IPC: A61L2/20
Filed: 2007-04-27
Abstract: A method of decontaminating articles, comprising the steps of: (a) moving a plurality of articles having a known temperature along a first path; (b) conveying a carrier gas along a second path that includes an elongated plenum, the second path intersecting the first path downstream from the plenum; (c) heating the carrier gas to a temperature of at least about 105°C at a location upstream of the plenum; (d) introducing into the carrier gas in the plenum an atomized mist of a liquid hydrogen peroxide of known concentration; and (e) controlling the following: (1) the volumetric flow of carrier gas along the second path; (2) the volume of hydrogen peroxide introduced into the carrier gas; and (3) the temperature of the carrier gas introduced into the plenum, such that the concentration of the vaporized hydrogen peroxide in the carrier gas where the first path intersects the second path has a dew point temperature below the known temperature of the articles.
Patent MX-358588-B (MX)
Title: Machine for machining a moving object.
Inventor: ANESI ANDREA
IPC: B23D21/00
Filed: 2015-05-07
Abstract: It is disclosed a machine for cutting a moving object. The cutting machine comprises conveyor means for carrying the object along an advancement direction at a line speed and comprises a driving and cutting unit configured to move in a cutting cycle according to a forward phase in order to perform the cutting of the moving object, and configured to move according to a return phase in order to return into the initial position of the cutting cycle. The cutting machine further comprises a processing unit configured to generate a driving signal for controlling the movement of the driving and cutting unit with an acceleration trend wherein the maximum absolute value of the acceleration within the return phase is smaller than the maximum absolute value of the acceleration within the forward phase.
Patent MX-349868-B (MX)
Title: Gel compositions.
Inventor: CARLOS GONZÁLEZ OJER
IPC: A61K31/522
Filed: 2013-12-16
Abstract: The present invention provides a gel combination comprising: polycarbophil in an amount comprised from 1 to 5% by weight; polyvinylpirrolidone in an amount comprised from 4 to 8% by weight; glycerine in an amount comprised from 1 to 10% by weight;and propyleneglycolin an amount comprised from 20 to 40% by weight;wherein:the weight ratio between polyvinylpirrolidone: polycarbophil is comprised between 1:1 and 4:1, the weight ratio between glycerine:polycarbophil is comprised from 0.5:1 to 2:1, and the weight ratio propyleneglycol:polycarbophil is comprised from 8:1 to 20:1. The invention also provides transparent compositions comprising such gel combinations as well as processes for their preparation and the use thereof as a medicament. Due to the specific excipients, % by weight, and weight ratiosforming the combination, the resultingcompositions show a high bioadhesivity and bioavailablity of the active ingredient, without toxic adverse effects.
Patent MX-360644-B (MX)
Title: Seated end process.
Inventor: BONSALL MICHAEL GEORGE
IPC: B21D51/34
Filed: 2013-12-06
Abstract: A method of attaching a metal end (7) to a metal container body (6) in order to close an opening in the body, wherein the body (6) has a curled lip at least partially surrounding the opening and the end (7) has an upstanding lip extending at least partially around a periphery thereof. The method comprises locating the end (7) within the body (6) at or near said opening, bringing a curling tool (8) into contact with said upstanding lip of the end (7) and applying a force to that lip, via the curling tool (8), in order to curl the upstanding lip around the curled lip of the body (6) to form interlocking curls.
Patent MX-359699-B (MX)
Title: Implantable arrangements for surgical staple cartridges.
Inventor: MORGAN JEROME R
IPC: A61B17/072
Filed: 2014-02-04
Abstract: A fastener cartridge (16000) can comprise a cartridge body (1 6010) comprising a deck (1601 1 ), fasteners removably stored within the cartridge body, and a layer assembly (16020) covering the deck. The cartridge body can comprise a longitudinal slot (16012) which can be configured to receive a cutting member (1 6030) therein. The layer assembly can comprise a first layer (16040) and a second layer (16050). A layer can comprise a first portion extending over the slot and a second portion (16043) located laterally with respect to the first portion and the slot. The first portion can comprise different properties than the second portion. For instance, the first portion can be thicker than the second portion. The first portion could also be stiffer than the second portion, for example. The first portion can rigidly support the tissue which is adjacent to a longitudinal cut extending through the tissue which is created by the cutting member. The second portion, positioned further away from the longitudinal cut in the tissue, can flexibly support such tissue.
Patent MX-365000-B (MX)
Title: Mcs table adaptation for 256-qam.
Inventor: GOLITSCHEK EDLER VON ELBWART ALEXANDER
IPC: H04W72/12
Filed: 2014-03-31
Abstract: The present invention relates to adaptive modulation and coding scheme selection and signaling in a communication system. In particular, a modulation and coding scheme to be used for transmission of a data is selected from a set of predetermined modulation and coding schemes. The predetermination of the set is performed by selecting the set from a plurality of predefined sets. The sets have the same size, so that a modulation and coding selection indicator signaled to select the modulation and coding scheme may be advantageously applied to any of the selected sets. Moreover, a second set includes schemes with a modulation not covered by the schemes of a first set, and which is of a higher order than any modulation in the first set.